Sage Journals: Discover world-class research

Abstract

Introduction

The purpose of this study is to determine the post-treatment levels of total oxidant status (TOS) and total antioxidant status (TAS), that are increased due to pathophysiology, and to compare those with pre-treatment levels in allergic rhinitis patients.

Material-Methods: Among 84 patients clinically diagnosed with allergic rhinitis, 31 patients were started only on nasal steroid treatment (mometasone furoate), and 53 patients were started on nasal steroid and oral antihistamine treatment (mometasone furoate + rupatadine fumarate 10 mg). Blood samples were taken from the patients at the first examination and at post-treatment month 1.TAS and TOS were measured from the blood samples.

Results

While no significant change was determined in mean TAS levels with treatment, a statistically significant decrease was determined in TOS values in post-treatment period (P < .01). There was no significant change in TAS and TOS values of patients only using nasal steroids, while a significant decrease was determined in post-treatment TOS values of patients using both nasal steroids and oral antihistamines (P < .001). It was determined that TOS values of women were significantly lower compared to men, and it was also reduced in seasonal allergic rhinitis compared to perennial allergic rhinitis (P < .05 for both).

Conclusion

In allergic rhinitis patients, concomitant use of nasal steroids and antihistamines significantly decreases total oxidative stress. It may be stated that the addition of antihistamines to allergic rhinitis treatment positively affects treatment.

Keywords

allergic rhinitis antihistamine antioxidant nasal steroid oxidant oxidative stress

Get full access to this article

View all access options for this article.

References

Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. (2004). Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 266: 37–56.

Castaner A, Roig E, Serra A, et al. (1990). Risk stratification and prognosis of patients with recent onset angina. Eur Heart J. 11: 868–875.

Uysal

Serbest radikaller, lipit peroksitleri ve organizmada prooksidan-antioksidan dengeyi etkileyen koşullar. Klinik Gelişim. 1998; 11:336–340.

Harman

Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956; 11(3):298–300.

Koch OR, Pani G, Borrello S, et al. (2004). Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Mol Aspects Med. 25: 191–198.

Lalwani

, eds. Current Diagnosis & Treatment in Otolaryngology-Head and Neck Surgery. New York: McGraw-Hill; 2004: 278.

Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on practice parameters in allergy, asthma and immunology. Ann Allergy Asthma Immunol. 1998; 81:478–518.

Bowler

Crapo

JD.

Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol. 2002; 110(3): 349–356.

Emin O, Hasan A, Aysegul D, Rusen D. Total antioxidant status and oxidative stress and their relationship to total IgE levels and eosinophil counts in children with allergic rhinitis. J Investig Allergol Clin Immunol. 2012;22(3):188–192.

10.

Sim CS, Lee JH, Kim SH, et al. Oxidative stress in schoolchildren with allergic rhinitis: propensity score matching case-control study. Ann Allergy Asthma Immunol. 2015;115(5):391–395.

11.

Bousquet J, Van Cauwenberge P, Khaltaev N. Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl):147–334.

12.

Serafini

Del Rio

Understanding the association between dietary antioxidants, redox status and disease: is the total antioxidant capacity the right tool?

Redox Rep. 2004; 9(3):145–152.

13.

Berlett

Stadtman

ER.

Protein oxidation in aging, disease, and oxidative stress. J Biol Chem. 1997; 272(33): 20313–20316.

14.

Motor S, Ozturk S, Ozcan O, et al. Evaluation of total antioxidant status, total oxidant status and oxidative stres index in patients with alopecia areata. Int J Clin Exp Med. 2014;7:1089–1093.

15.

Aydın M, Selcoki Y, Nazlı Y, et al. Relationship between total antioxidant capacity and the severity of coronary artery Disease. J Clin Exp Invest. 2012;3:22–28.

16.

Şahin DY, Elbasan Z, Gür M, et al. Relationship beoxidative stress markers and cardiac syndrome X. J Clin Exp Invest. 2012;3:174–180.

17.

Akbay E, Arbağ H, Uyar Y, Öztürk K. Oxidative stress and antioxidant factors in pathophysiology of allergic rhinitis. Tr-ENT. 2007;17(4):189–196.

18.

Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466–476.

19.

Nathan

RA.

Management of patients with allergic rhinitis and asthma: literature review. South Med J. 2009; 102(9):935–941.

20.

Bousquet J, van Cauwenberge P, Aït Khaled N, et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy. 2006;1(9):1086–1096.

21.

Stanić D, Plećaš-Solarović B, Petrović J, et al. Hydrogen peroxide-induced oxidative damage in peripheral blood lymphocytes from rats chronically treated with corticosterone: The protective effect of oxytocin treatment. Chem Biol Interact. 2016;256:134–141.

22.

Riediker M, Monn C, Koller T, Stahel WA, Wuthrich B. Air pollutants enhance rhinoconjunctivitis symptoms in pollen-allergic individuals. Ann Allergy Asthma Immunol. 2001;87:311–318.

23.

Chen H, Zhang L, Lou H, Wang Y, Cao F, Wang C. A Randomized Trial of Comparing a Combination of Montelukast and Budesonide With Budesonide in Allergic Rhinitis [published online ahead of print, 2019 Nov 29]. Laryngoscope. doi:10.1002/lary.28433